ACTC Insider Trading Activity and SEC Form 4 Filings
ACTC insider trading summary
No open-market insider purchases or sales of Advanced Cell Technology, Inc. (ACTC) have been reported on SEC Form 4 in the past 12 months.
Latest ACTC insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jul 7, 2014 | Robert Lanza | Chief Scientific Officer | Sell | $60K (745,000 @ $0.08) |
| Jul 3, 2014 | Robert Lanza | Chief Scientific Officer | Sell | $60K (755,000 @ $0.08) |
| Jan 10, 2013 | Gary H Rabin | CEO & CFO | Sell | $79K (1,000,000 @ $0.08) |
| Dec 14, 2012 | Robert Lanza | Chief Scientific Officer | Sell | $9K (150,000 @ $0.06) |
| Dec 14, 2012 | Robert Lanza | Chief Scientific Officer | Sell | $26K (440,000 @ $0.06) |
| Dec 14, 2012 | Robert Lanza | Chief Scientific Officer | Sell | $3K (43,000 @ $0.06) |
| Dec 14, 2012 | Robert Lanza | Chief Scientific Officer | Sell | $2K (40,000 @ $0.06) |
| Dec 14, 2012 | Robert Lanza | Chief Scientific Officer | Sell | $6K (100,000 @ $0.06) |
| Dec 14, 2012 | Robert Lanza | Chief Scientific Officer | Sell | $32K (545,490 @ $0.06) |
| Dec 14, 2012 | Robert Lanza | Chief Scientific Officer | Sell | $1K (20,000 @ $0.06) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.